189 related articles for article (PubMed ID: 33544468)
41. YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis.
You Q; Yao Y; Wu J; Cheng C; Li Y; Yuan H
Biomed Pharmacother; 2020 Sep; 129():110339. PubMed ID: 32563147
[TBL] [Abstract][Full Text] [Related]
42. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
43. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
[TBL] [Abstract][Full Text] [Related]
44. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
45. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
[TBL] [Abstract][Full Text] [Related]
46. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
47. LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.
Zhao W; Zhao J; Guo X; Feng Y; Zhang B; Tian L
BMC Cancer; 2021 Feb; 21(1):142. PubMed ID: 33557774
[TBL] [Abstract][Full Text] [Related]
48. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
50. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
Zhang D; Li H; Xie J; Jiang D; Cao L; Yang X; Xue P; Jiang X
Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p.
Guan C; Zhao Y; Wang W; Hu Z; Liu L; Li W; Jiang X
Cancer Biother Radiopharm; 2024 Apr; 39(3):178-187. PubMed ID: 32907346
[No Abstract] [Full Text] [Related]
52. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
53. LncRNA NEAT1 Targets Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via the miR-410-3p/YY1 Axis.
Wang Y; Hou L; Yuan X; Xu N; Zhao S; Yang L; Zhang N
Front Immunol; 2020; 11():1975. PubMed ID: 32983133
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
55. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
[TBL] [Abstract][Full Text] [Related]
56. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
58. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma.
Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W
Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506
[TBL] [Abstract][Full Text] [Related]
59. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
Tian JB; Cao L; Dong GL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
[TBL] [Abstract][Full Text] [Related]
60. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
Peng L; Liu YH; Nie S; Gao M
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
